
GMAB vs RPRX
$GMAB vs $RPRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GMAB vs RPRX: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Both are in uptrends, trading above their 50- and 200-day averages, so this compares two names the market is already bidding up.
- ·Both beat the market over the past year: GMAB +67.4% and RPRX +75.3%, against the S&P 500 at +8.8%.
- ·The last month has flipped the order: GMAB leads over the month (+29.3% against +9%) even though RPRX leads over the year.
- ·RPRX has support 12.6% below at $59.30; GMAB has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GMAB vs RPRX: the quick read
- ·GMAB is the larger company by market cap ($31.81B vs $26.65B).
- ·GMAB has been more active on our scanner (195 vs 85 alerts in 30 days).
- ·RPRX has the smaller float (336.4M vs 615.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 195 and 85 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 19% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both are trading in the upper quarter of their 52-week range, so neither is a pullback candidate right now.
- ·RPRX pays a dividend and GMAB does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching GMAB or RPRX? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GMAB and RPRX on TheDesperateTrader.
- Is GMAB or RPRX the better stock?
- "Better" depends on your goal, and these two are not alike. GMAB is the larger company by market cap ($31.81B vs $26.65B). GMAB has been more active on our scanner (195 vs 85 alerts in 30 days). RPRX has the smaller float (336.4M vs 615.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GMAB and RPRX?
- The differences that matter: they are not in the same business - GMAB is pharmaceutical preparations and RPRX is pharmaceutical preparations; they are similar in size ($31.81B vs $26.65B); they trade at very different share prices ($51.15 vs $67.82); GMAB sits at 76% of its 52-week range against 92% for RPRX; only RPRX pays a dividend; our scanner flagged GMAB 195 times in the last 30 days against 85 for RPRX. Everything above is measured from the latest completed session and SEC filings.
- Which of GMAB and RPRX is more active right now?
- Right now GMAB is at about 0.5x its normal volume and RPRX is at about 1.0x, so RPRX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GMAB or RPRX in the stronger trend?
- GMAB is above its 50-day average of $42.62 and above its 200-day average of $31.91; RPRX is above its 50-day average of $62.11 and above its 200-day average of $55.14. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GMAB or RPRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GMAB and RPRX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.